Erchonia Medical, Inc. was founded in 1996 in order to advance the art and science of health through the development and distribution of technologically superior bio-medical products, such as the Erchonia 3 LT™ lasers. We made history by becoming the first Low Level Laser company to receive a FDA (510k) market clearance in January 2002, after doing two double-blind randomized clinical trials. Since then we have been granted three more (510k) market clearances and are continuing our mission to be the most researched laser in the world.
